Page last updated: 2024-11-07

dihydronitidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dihydronitidine: molecular structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID99641
CHEMBL ID487807
SCHEMBL ID11749474
MeSH IDM0211857

Synonyms (19)

Synonym
dihydronitidine
NSC254666 ,
nsc-254666
13063-06-4
nitidine, dihydro
[1,6-c]phenanthridine, 12,13-dihydro-2,3-dimethoxy-12-methyl-
nitidine, dihydro-
c21h19no4
2,3-dimethoxy-12-methyl-13h-[1,3]benzodioxolo[5,6-c]phenanthridine
CHEMBL487807
5,6-dihydronitidine
(1,3)benzodioxolo(5,6-c)phenanthridine, 12,13-dihydro-2,3-dimethoxy-12-methyl-
nsc 254666
SCHEMBL11749474
MTVOSXTZNVKGIF-UHFFFAOYSA-N
2,3-dimethoxy-12-methyl-12,13-dihydro[1,3]benzodioxolo[5,6-c]phenanthridine #
[1,3]benzodioxolo[5,6-c]phenanthridine, 12,13-dihydro-2,3-dimethoxy-12-methyl-
DTXSID20156654
12,13-dihydro-2,3-dimethoxy-12-methyl-(1,3)benzodioxolo(5,6-c)phenanthridine

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"To develop a novel anti-cancer drug of low side effect against lung adenocarcinoma, the authors screened the bioresources of Okinawa Island, Japan."( Tumor-selective cytotoxicity of benzo[c]phenanthridine derivatives from Toddalia asiatica Lam.
Iwasaki, H; Okabe, T; Oku, H; Shimatani, M; Takara, K; Toda, T, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1698175Inhibition of anti-human CD3/CD28/mAbs-stimulated human T-cell proliferation after 72 hrs by CFSE staining based flow cytometric analysis
AID338342In vivo antitumor activity against mouse P388 cells at 30 to 50 mg/kg, ip relative to control
AID1236963Antiproliferative activity against human HL60 cells assessed as inhibition of cell viability after 48 hrs by WST-1 assay2015Bioorganic & medicinal chemistry letters, Jul-15, Volume: 25, Issue:14
Antiproliferative activity of O4-benzo[c]phenanthridine alkaloids against HCT-116 and HL-60 tumor cells.
AID1236962Antiproliferative activity against human HCT116 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Jul-15, Volume: 25, Issue:14
Antiproliferative activity of O4-benzo[c]phenanthridine alkaloids against HCT-116 and HL-60 tumor cells.
AID1698177Cytotoxicity against human T-cell assessed reduction in cell viability at 30 uM after 72 hrs
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]